科創信息(300730.SZ):第一大股東由財信金服變更為財信數科
格隆匯9月8日丨科創信息(300730.SZ)公佈,2022年9月8日,公司收到財信數科轉來的中國證券登記結算有限責任公司出具的《證券過户登記確認書》,確認該次國有股份無償劃轉的股份過户登記手續已辦理完成。
該次國有股份無償劃轉前,財信金服持有公司股份3215.4636萬股,佔公司當前總股本的13.41%,財信數科未持有公司股份;該次國有股份無償劃轉完成後,財信金服不再持有公司股份,財信數科持有公司股份3215.4636萬股,佔公司當前總股本的13.41%。
該次國有股份無償劃轉已於2022年9月7日完成過户登記,公司第一大股東由財信金服變更為財信數科。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.